Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant

Journal of Clinical Investigation

Volumn 87, Issue 5, 1991, Pages 1490-1495

  Arnett, Frank C ^a   Olsen, Mary L ^a   Anderson, Kent L ^a   Reveille, John D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Antiphospholipid antibodies; Autoantibodies; HLA class II alleles; Restriction fragment length polymorphism; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; HLA DQ ANTIGEN; HLA DR ANTIGEN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; HUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ALLELES; AUTOANTIBODIES; BLOOD COAGULATION FACTORS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMAN; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHOSPHOLIPIDS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025763925     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI115158     Document Type: Article

References (44)

1. Love, P. E., and S. A. Santoro. 1990. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann. Intern. Med. 112:682-698.
2. Conley, C. L., and C. Hartman. 1953. A haemorrhagic disorder caused by circulating anticoagulants in patients with disseminated lupus erythematosus. J. Clin. Invest. 31:621-623.
3. Feinstein, D. I., and S. I. Rappaport. 1972. Acquired inhibitors of blood coagulation in five patients. In Progress in Haemostasis and Thrombosis. Vol. 1. T. H. Spaet, editor. Grune and Stratton, Inc., New York. 75-79.
4. Harris, E. N., A. E. Gharavi, M. L. Bowie, B. M. Patel, C. G. Mockworth-Young, S. Loizou, and G. R. V. Hughes. 1983. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet ii: 1211-1214.
5. Asherson, R. A., M. A. Khamashta, J. Ordi-Ros, R. H. W. M. Derksen, S. J. Machin, J. Barquinero, H. H. Outt, E. N. Harris, M. Vilardell, and G. R. V. Hughes. 1989. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Balt.). 68:366-374.
6. Harris, E. N., E. Baguley, R. A. Asherson, and G. R. V. Hughes. 1987. Clinical and serological features of the "antiphospholipid syndrome". Br. J. Rheumatol. 26:19. (Abstr.)
7. Hart, R. G., V. T. Miller, B. M. Coull, and V. Bril. 1984. Cerebral infarction associated with lupus anticoagulants: preliminary report. Stroke. 15:114-118.
8. Trimble, M., D. A. Bell, W. Brien, V. Hachinski, B. O'Keefe, C. McLay, and J. Black. 1990. The antiphospholipid syndrome: prevalence among patients with stroke and transient ischemic attacks. Am. J. Med. 88:593-597.
9. Reinertsen, J. L.. J. H. Klippel, A. H. Johnson, A. D. Steinberg, J. L. Decker, and D. L. Mann. 1978. B-Lymphocyte alloantigens associated with systemic lupus erythematosus. N. Engl. J. Med. 299:515-518.
10. Gibofsky, A., R. J. Winchester, M. Patarroyo, M. Fotino, and H. G. Kunkel. 1978. Disease associations of the Ia-like human alloantigens: contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus. J. Exp. Med. 148:1728-1732.
11. Bell, D. A., and P. J. Maddison. 1980. Serologic subsets in systemic lupus erythematosus. An examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum. 23:1268-1273.
12. Ahearn, J. M., T. T. Provost, C. A. Stevens, W. B. Bias, and F. C. Arnett. 1982. Interrelationships of HLA-DR, MB and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum. 25:1031-1040.
13. Gammon, W. R., E. R. Heise, W. A. Burke, J. Fine, D. T. Woodley, and R. A. Briggaman. 1988. Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II associated. J. Invest. Dermatol 91:228-232.
14. Gregerson, P. K. 1989. Biology of disease. HLA class II polymorphism: implications for genetic susceptibility to autoimmune disease. Lab. Invest. 61:5-19.
15. Hamilton, R. G., J. B. Harley, W. B. Bias, M. Roebber, M. Reichlin, M. C. Hochberg, and F. C. Arnett. 1988. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum. 31:496-505.
16. Johnson, C. D., J. P. Edmonds, and E. J. Holborow. 1973. Precipitating antibody to DNA detected by two-stage electroimmunodiffusion. Lancet. ii:883-886.
17. Aarden, L. A., E. R. deGroot, and T. E. W. Feltkamp. 1975. Immunology of DNA III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann. NY Acad. Sci. 254:505-515.
18. Blin, N., and D. W. Stafford. 1978. A general method for isolation of high molecular weight DNA from eukaroytes. Nucleic Acids Res. 3:2303-2308.
19. McDaniel, D. O., R. T. Acton, B. O. Barger, W. J. Koopman, and J. D. Reveille. 1987. Association of 9.2 kilobase PvuII class I major histocompatibility complex restriction fragment length polymorphism with ankylosing spondylitis. Arthritis Rheum. 30:894-900.
20. Long, E. O., C. T. Wake, J. Gorski, and B. Mach. 1983. Complete sequence of an HLA-DRβ chain genes. EMBO (Eur. Mol. Biol. Organ.) J. 2:389-394.
21. Larhammar, D., J. J. Hyldig-Nielsen, B. Servenius, G. Anderson, L. Rask, and P. A. Peterson. 1983. Exon-intron organization and complete nucleotide sequence of a human major histocompatibility antigen DC/9 gene. Proc. Natl. Acad. Sci. USA. 80:7313-7317.
22. Spielman, R. S., J. Lee, W. F. Bodmer, J. G. Bodmer, and J. Trowsdale. 1984. Six HLA-D region α-chain genes on human chromosome 6: polymorphisms and associations of DQα-related sequences and DR types. Proc. Natl. Acad. Sci. USA. 81:3461-3465.
23. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabelling DNA restriction fragments to high specific activity. Anal. Biochem. 132:6-13.
24. Cohen, D., M. Simons, J. M. Lalouel, and B. DuPont. 1988. Nomenclature for HLA-RFLP. Tenth International Histocompatibility Workshop Newsletter. 2:44-51.
25. Reveille, J. D., R. R. Schrohenloher, R. T. Acton, and B. O. Barger. 1989. DNA analysis of HLA-DR and DQ genes in American blacks with systemic lupus erythematosus. Arthritis Rheum. 32:1243-1251.
26. Reveille, J. D., R. T. Acton, K. Anderson, B. O. Barger, and R. E. Schrohenloher. 1990. RFLPanalysis of HLA-DR, DQ, DP and C4 alleles in Caucasians with systemic lupus erythematosus. J. Rheumatol. In press.
27. Kohonen-Corish, M. R. J., and S. W. Serjeantson. 1986. HLA-DRβ polymorphism revealed by Taq I correlate with HLA-DR specificities. Hum. Immunol. 15:263-271.
28. Carlsson, B., J. Wallin, J. Bohme, and E. Moller. 1987. HLA-DR-DQ haplotypes denned by restriction fragment analysis: correlation to serology. Hum. Immunol. 20:95-113.
29. MacMurray, A. J., J. I. Bell, D. Denney, D. Watling, L. S. Foster, and H. O. McDevitt. 1987. Molecular mapping of class II polymorphisms in the human major histocompatibility complex. II. DQβ. J. Immunol. 139:574-586.
30. Bell, J. I., D. Denney, A. MacMurray, L. Foster, D. Watling, and H. O. McDevitt. 1987. Molecular mapping of class II polymorphisms in the human major histocompatibility complex. I. DRβ. J. Immunol. 139:562-573.
31. Bidwell, J. L., E. A. Bidwell, D. A. Savage, D. Middleton, P. T. Klouda, and B. A. Bradley. 1988. A DNA-RFLP typing system that positively identifies serologically well defined and ill defined HLA-DR and DQ alleles. including DRw10. Transplantation. 45:640-646.
32. Gyllensten, U. B., and H. A. Erlich. 1988. Generation of single-stranded DNA by polymerase chain reaction and its application to direct sequencing of the HLA-DQα locus. Proc. Natl. Acad. Sci. USA. 86:7652-7856.
33. Bodmer, J. G., S. G. E. Marsh, P. Parham, H. A. Erlich, E. Albert, W. F. Bodmer, B. Dupont, B. Mach, W. R. Mayr, T. Sasazuki, G. M. Th. Schreuder, J. L. Strominger, A. Svejgaard, and P. I. Terasaki. 1990. Nomenclature for factors of the HLA system. 1989. Hum. Immunol. 28:326-342.
34. Tan, E. M., A. S. Cohen, F. F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, J. G. Schaller, N. Talal, and R. J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1271-1277.
35. Todd, J. A., H. Acha-Orbea, J. I. Bell, N. Chao, Z. Fronek, C. O. Jacob, M. M. McDermott, A. A. Sinha, L. Timmerman, E. Steinman, and H. O. McDevitt. 1988. A molecular basis for MHC Class II-associated autoimmunity. Science (Wash. DC). 240:1003-1009.
36. Harley, J. B., M. Reichlin, F. C. Arnett, E. L. Alexander, W. B. Bias, and T. T. Provost. 1986. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren's syndrome. Science (Wash. DC). 232:1145-1147.
37. Goldstein, R., M. Duvic, I. N. Targoff, M. Reichlin, A. M. McMenemy, J. D. Reveille, N. B. Warner, M. S. Pollack, and F. C. Arnett. 1990. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum. 33:1240-1248.
38. Isern, R., F. C. Arnett, R. Goldstein, K. Anderson, E. Durban, D. Owerbach, and J. D. Reveille. 1990. Anti-centromere antibodies (ACA) are associated with HLA-DR/31 third hypervariable sequences shared by HLA-DR1 and DR4. Arthritis Rheum. 33:S32. (Abstr.)
39. Reveille, J. D., M. J. MacLeod, K. Whittington, and F. C. Arnett, 1990. The Ro/La autoantibody response is localized to the second hypervariable region of HLA-DQα and DQβ outermost domains. Arthritis Rheum. 33:599. (Abstr.)
40. Olsen, M. L., F. C. Arnett, and J. D. Reveille. 1990. Anti-Sm and anti-RNP antibodies are associated with distinct and different HLA-DQα and β chain genes. Arthritis Rheum. 33:S100. (Abstr.).
41. Khanduja, S., F. C. Arnett, and J. D. Reveille. 1990. HLA-DQ beta genes encode an epitope for lupus specific DNA antibodies. Clin. Res. In press.
42. Savi, M., G. F. Ferraccioli, T. M. Neri, P. Zanelli, P. P. Dall'Aglio, A. Tincani, G. Balestrieri, G. Carella, and R. Cattaneo. 1988. HLA-DR antigens and anticardiolipin antibodies in Northern Italian systemic lupus erythematosus patients. Arthritis Rheum. 31:1568-1570.
43. McHugh, N. J., and P. J. Maddison. 1989. HLA-DR antigens and anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 32:1623-1624.
44. Brown, J. H., T. Jardetzky, M. Saper, B. Samraoui, P. Bjorkman, and D. C. Wiley. 1988. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature (Lond.). 332:6012-6015.